|1.||Martin, Sarah: 2 articles (10/2012 - 12/2011)|
|2.||Petrikovics, Ilona: 2 articles (10/2012 - 12/2011)|
|3.||Waghmare, Chandrakant: 1 article (05/2014)|
|4.||Kumar, Deo: 1 article (05/2014)|
|5.||Singh, Anil Kumar: 1 article (05/2014)|
|6.||Gopalan, Natarajan: 1 article (05/2014)|
|7.||Bhattacharya, Rahul: 1 article (05/2014)|
|8.||Palit, Meehir: 1 article (05/2014)|
|9.||Singh, Poonam: 1 article (05/2014)|
|10.||Yang, Jijin: 1 article (01/2013)|
05/01/2014 - "ATCA concentration in plasma and urine was found to be more reliable indicator of cyanide poisoning."
10/26/2012 - "This finding suggests that ATCA has the potential to serve as a plasma biomarker / forensic biomarker for cyanide poisoning."
01/17/1987 - "[Arginine thiazolidinecarboxylate poisoning]."
10/26/2012 - "ATCA levels following the administration of different doses of potassium cyanide (KCN) to mice were measured and compared to endogenous ATCA levels in order to study the significance of using ATCA as a biomarker for cyanide poisoning. "
10/26/2012 - "To demonstrate the potential of using 2-aminothiazoline-4-carboxylic acid (ATCA) as a novel biomarker/forensic biomarker for cyanide poisoning. "
|2.||Chronic Hepatitis (Chronic Active Hepatitis)
01/01/1984 - "Forty-four patients with chronic active hepatitis were given arginine thiazolidinecarboxylate (800 mg/day per os for 40 days) or placebo in a randomized, double-blind trial. "
01/01/1984 - "Arginine thiazolidinecarboxylate in the treatment of chronic active hepatitis: double-blind comparison with placebo."
|3.||Carbon Tetrachloride Poisoning
|4.||Body Weight (Weight, Body)
10/26/2012 - "ATCA concentration in mice plasma samples were increased from 189 ± 28 ng/mL (n = 3) to 413 ± 66 ng/mL (n = 3) following a 10 mg/kg body weight dose of KCN introduced subcutaneously. "
12/01/2011 - "In this report, in vivo production of ATCA and its distributions in plasma and organs were studied after a subcutaneous sublethal dose of 4 mg/kg body weight potassium cyanide (KCN) administration to rats. "
|5.||Atherosclerotic Plaque (Atheroma)
01/01/2013 - "The ATCA is specifically internalized by CD36 receptors on atherosclerotic plaque providing enhanced visualization of lesions under physiological conditions. "
01/01/2013 - "The ability of ATCA to detect atherosclerotic plaque lesions in vivo was assessed using CMR. "
01/01/2013 - "The ATCA exhibited time-dependent accumulation in atherosclerotic plaque lesions of ApoE -/- mice as determined using CMR. "
|2.||arginine thiazolidinecarboxylate (ATCA)
|6.||Apolipoproteins E (ApoE)
|7.||antineoplaston A10 (A 10)